Snapshot

DOI:

Continue learning with EuroIntervention!

With the excitement of EuroPCR now in the past – and it was a wonderful moment to reconnect with colleagues and learn together – we move forward with thoughtful, original research on topics encompassing devices, techniques and, of course, the well- being of our patients.

Short DAPT after NSTE-ACS in HBR patients

Davide Cao, Roxana Mehran and colleagues compare the impact of 1 versus 3 months of dual antiplatelet therapy on the clinical outcomes of high bleeding risk patients undergoing percutaneous coronary intervention (PCI) due to non-ST-segment elevation acute coronary syndrome or chronic coronary syndrome. In their findings, a very short duration of dual antiplatelet therapy appears to be a valid bleeding avoidance strategy for these patients.

Early discharge after large-bore CTO PCI

Same-day discharge can augment patient comfort and decrease economic costs, but is this a feasible and safe practice for patients undergoing large-bore chronic total occlusion PCI? Yvemarie B.O. Somsen, Paul Knaapen and colleagues examine a CTO PCI registry and find that same-day discharge was achieved successfully in over 60% of patients, with low rates of overall vascular access complications.

Impact of calcium morphologies on IVL efficacy

Although calcium modification is recommended before stenting, do different calcium morphologies impact the efficacy of intravascular lithotripsy? Angela McInerney, Nieves Gonzalo and colleagues use optical coherence tomography to assess final stent parameters in patients undergoing intravascular lithotripsy for the treatment of calcified coronary artery disease.

Ultrathin-strut versus thin-strut BP-SES: healing and outcomes

Ryutaro Ikegami, Farouc A. Jaffer and colleagues study how the strut thickness of ultrathin-strut versus thin-strut biodegradable-polymer sirolimus-eluting stents impacts vessel healing and clinical outcomes at 30 days and 1 year. Given that the clinical outcomes were similar, they postulate that the benefits of biodegradable-polymer sirolimus-eluting stents may be independent of the strut thickness.

Volume 20 Number 10
May 20, 2024
Volume 20 Number 10
View full issue

Suggested by Cory

Research Correspondence

10.4244/EIJ-D-25-00068 Jul 21, 2025
Intracoronary nicardipine to induce hyperaemia
Viscusi M et al

Editorial

10.4244/EIJ-E-25-00023 Jul 21, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial
Cuisset T and Cayla G
free

Viewpoint

10.4244/EIJ-D-24-00943 Jul 21, 2025
Factor XI inhibition for ACS patients: premises and prospects
Lopes R and Fanaroff A
free

State-of-the-Art

10.4244/EIJ-D-24-00387 Jul 21, 2025
Advances in coronary imaging of atherosclerotic plaques
Garcia-Garcia H et al
free

Research Correspondence

10.4244/EIJ-D-25-00025 Jul 21, 2025
Validation of the pullback pressure gradient in resting conditions
Sakai K et al

Editorial

10.4244/EIJ-E-25-00031 Jul 21, 2025
Supersaturated oxygen therapy to reduce myocardial infarct size: time to pay attention!
Stone G and Akinmolayemi O
free
Trending articles
224.5

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.65

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
80.3

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
47.75

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
47.75

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
23.7

Expert review

10.4244/EIJ-D-18-01180 Feb 20, 2020
Technical aspects in coronary sinus Reducer implantation
Giannini F et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved